| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |